学术探索
学术期刊
新闻热点
数据分析
智能评审

THE EFFECTS OF FIBRATES ON LIPOPROTEIN AND HEMOSTATIC CORONARY RISK-FACTORS

被引：63
作者：
SCHONFELD, G
机构：
[1] Div. Atherosclerosis, Nutrition and Lipid Research, Washington University School of Medicine, St. Louis, MO 63110
来源：
ATHEROSCLEROSIS | 1994年 / 111卷 / 02期
关键词：
FIBRATES; FENOFIBRATE; CLOFIBRATE; BEZAFIBRATE; GEMFIBROZIL; CIPROFIBRATE; THROMBOSIS; FIBRINOLYSIS; HYPERLIPIDEMIA; COAGULATION; ATHEROSCLEROSIS;
D O I：
10.1016/0021-9150(94)90090-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The effects of fibrates on lipoprotein profiles and lipoprotein physiology, as well as on selected coagulation and fibrinolytic factors are reviewed. It is concluded that the action of fibrates on these systems is such as to render the fibrates beneficial in atherosclerosis prevention.
引用
收藏
页码：161 / 174
页数：14
相关论文
共 175 条
[51]  
EISENBERG S, 1990, CURR OPIN LIPIDOL, V1, P34
[52]   COMPARATIVE EFFICACY AND SAFETY OF MICRONIZED FENOFIBRATE AND SIMVASTATIN IN PATIENTS WITH PRIMARY TYPE IIA OR IIB HYPERLIPIDEMIA [J].
FARNIER, M ;
BONNEFOUS, F ;
DEBBAS, N ;
IRVINE, A .
ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (04) :441-449
[53]  
FERREIRA IJ, 1981, ARZNEIMITTEL-FORSCH, V31-2, P1859
[54]  
FIEVET C, 1990, CURR THER RES CLIN E, V47, P353
[55]   EFFICACY OF GEMFIBROZIL IN DYSLIPIDEMIC SUBJECTS WITH SUSPECTED HEART-DISEASE - AN ANCILLARY STUDY IN THE HELSINKI HEART-STUDY FRAME POPULATION [J].
FRICK, MH ;
HEINONEN, OP ;
HUTTUNEN, JK ;
KOSKINEN, P ;
MANTTARI, M ;
MANNINEN, V .
ANNALS OF MEDICINE, 1993, 25 (01) :41-45
[56]   HELSINKI HEART-STUDY - PRIMARY-PREVENTION TRIAL WITH GEMFIBROZIL IN MIDDLE-AGED MEN WITH DYSLIPIDEMIA - SAFETY OF TREATMENT, CHANGES IN RISK-FACTORS, AND INCIDENCE OF CORONARY HEART-DISEASE [J].
FRICK, MH ;
ELO, O ;
HAAPA, K ;
HEINONEN, OP ;
HEINSALMI, P ;
HELO, P ;
HUTTUNEN, JK ;
KAITANIEMI, P ;
KOSKINEN, P ;
MANNINEN, V ;
MAENPAA, H ;
MALKONEN, M ;
MANTTARI, M ;
NOROLA, S ;
PASTERNACK, A ;
PIKKARAINEN, J ;
ROMO, M ;
SJOBLOM, T ;
NIKKILA, EA .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (20) :1237-1245
[57]   EFFECT OF FENOFIBRATE TREATMENT ON TYPE-III HYPERLIPOPROTEINEMIA [J].
FRUCHART, JC ;
DAVIGNON, J ;
BARD, JM ;
GROTHE, AM ;
RICHARD, A ;
FIEVET, C .
AMERICAN JOURNAL OF MEDICINE, 1987, 83 (5B) :71-74
[58]   DIRECT EFFECTS OF GEMFIBROZIL ON THE FIBRINOLYTIC SYSTEM - DIMINUTION OF SYNTHESIS OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 [J].
FUJII, S ;
SOBEL, BE .
CIRCULATION, 1992, 85 (05) :1888-1893
[59]  
FURIE B, 1992, NEW ENGL J MED, V326, P800
[60]  
FUSTER V, 1992, CIRCULATION, V86, P1
12345678910